The Importance of Community in Health Care
Dermatology Times
FEBRUARY 27, 2025
Independent pharmacies are closing at high rates, leaving many communities without essential health care access.
Dermatology Times
FEBRUARY 27, 2025
Independent pharmacies are closing at high rates, leaving many communities without essential health care access.
MedEsthetics
FEBRUARY 27, 2025
Allergan Aesthetics announced an open casting call for women in the U.S. whove experienced breast reconstruction and/or augmentation to share their stories and be featured in the Faces of Natrelle campaign.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Salon Today
FEBRUARY 27, 2025
On Day 3 of our SALON TODAY 200, we tip our hats to the honorees who embrace the latest tech features, apps and programs to improve their operations, including Owner AnneMarie Krainich of Lehi, Utah.
Dermatology Times
FEBRUARY 27, 2025
Objective tools like IGA and EASI provide structured severity assessment but often lack patient-reported insights such as itch severity.
US Dermatologt Partners
FEBRUARY 27, 2025
Independent Medical Systems (IMS) is proudly accepted by our dermatologists in Mount Pleasant. A member of our team can help you estimate your coverage during your consultation.
Dermatology Times
FEBRUARY 27, 2025
Dermatology Times is looking back on the top stories in dermatology from the month of February.
Esthetician Leadership Today brings together the best content for skin care professionals from the widest variety of industry thought leaders.
Dermatology Times
FEBRUARY 27, 2025
Nonsteroidal AD therapies are gaining attention due to their rapid effectiveness and ability to offer an alternative to long-term steroid use.
Spa Industry Association
FEBRUARY 27, 2025
Smart skincare featuring time-release encapsulation for Your Everchanging Skin earns numerous international awards and the trust of over 1,700 spa professionals worldwide. (Heiloo, Netherlands) February 25, 2025. LOOkX, a globally recognized clinical skincare brand utilizing innovative techniques, is excited to announce its launch in the U.S. market.
Dermatology Times
FEBRUARY 27, 2025
Dermatology Times is recapping our top expert interviews from the month of February.
Lipgloss and Aftershave
FEBRUARY 27, 2025
AmSpas 2025 The Medical Spa Show is April 10-13, 2025! L+A readers can enjoy a $100 Savings Code. Were thrilled to share L+As Favorite Brands At The Medical Spa Show. L+A Set To Interview Industry Leaders at AmSpa in Las Vegas Barry Eichner and Dr. Chantal Lunderville of L+A will provide exclusive press coverage of The Medical Spa Show by AmSpa, the premier trade show in the United States dedicated exclusively to medical spas and non-surgical medical aesthetics.
Dermatology Times
FEBRUARY 27, 2025
Catch up on dermatology news, highlights, and insights from the past 24 hours.
Lira Clinical
FEBRUARY 27, 2025
Can what you eat really make or break your skin? If youre struggling with acne, a good skincare routine is keybut whats on your plate might be just as important for achieving clear, healthy skin from the inside out!Metaxia and Francine are joined by nutritionist Maria Marlowe, who specializes in acne and is the author of "The Real Food Guide" and "Be Healthy Every Day.
Dermatology Times
FEBRUARY 27, 2025
The panelist discusses how to effectively communicate the benefits and potential adverse effects of dupilumab treatment to patients and their families to support informed decision-making.
Beautiful With Brains - Antiaging
FEBRUARY 27, 2025
Is it me or every time we think weve got our skincare routine sorted, some new ingredient pops up, right? Like, we know retinol is the gold standard of anti-aging. I build my entire skincare routine around it and bam, retinyl propionate arrives on the market and gets all the buzz. I admit I’m quick […] The post Retinyl Propionate VS Retinol: Which Is Better For Your Skin?
Dermatology Times
FEBRUARY 27, 2025
The panelist discusses how to optimize topical therapy selection and application strategies for a young man with mild atopic dermatitis to achieve symptom control and maintain skin barrier function.
Alison Bladh
FEBRUARY 27, 2025
Navigating the journey of perimenopause brings a host of changes, and for some women, unexpected skin issues like late-onset acne can emerge. This resurgence or new occurrence of acne during midlife can be both surprising and frustrating. While hormonal fluctuations play a significant role, they aren't the only factor. Let's delve into why this happens and explore effective management strategies, including nutritional advice, lifestyle modifications, professional salon treatments, and skincare r
Dermatology Times
FEBRUARY 27, 2025
Christophe Piketty, MD, PHD, provides a deeper look at the promise of nemolizumab in addressing unmet needs faced by patients with atopic dermatitis and prurigo nodularis.
The Dermatology Digest
FEBRUARY 27, 2025
Delgocitinib cream (Anzupgo, LEO Pharma) met its primary endpoint in the Phase 3 DELTA China Trial of Chinese patients with moderate-to-severe chronic hand eczema (CHE). The primary endpoint for DELTA China was the Investigators Global Assessment for Chronic Hand Eczema Score (IGA-CHE TS) at Week 16, which was met with a statistically significant improvement in CHE severity after 16 weeks of treatment with delgocitinib cream compared to cream vehicle.
Dermatology Times
FEBRUARY 27, 2025
Belgian patients receiving biologics had faster response rates compared to phototherapy, systemic, and topical treatments.
Texas Dermatology
FEBRUARY 27, 2025
BroadBand Light (BBL) laser treatment is a cutting-edge skin rejuvenation therapy designed to target various skin concerns, including sun damage, pigmentation issues, redness, acne scars, and fine lines. At Texas Dermatology, BBL is a popular treatment choice for individuals seeking a non-invasive yet highly effective way to achieve clearer, more youthful-looking skin.
Dermatology Times
FEBRUARY 27, 2025
After just 2 weeks of twice-daily use, a pediatric patient saw visually improved skin with no adverse events.
Dermatology Times
FEBRUARY 27, 2025
DELTA China follows the success of European and Canadian trials, reinforcing delgocitinibs potential as a global treatment for CHE.
Let's personalize your content